Prof. MD. Hakan Alagözlü

Education and Expertise (Education and Expertise)

• Gazi University Faculty of Medicine - Medical Education (Medical Education)
• Cumhuriyet University Faculty of Medicine Hospital Internal Medicine - Specialization (Specialization)
• Gazi University Faculty of Medicine Hospital Gastroenterology - Specialization (Specialization)

Experience (Experience)

• SUNY (State University of New York) Downstate Medical Center, University Hospital of Brooklyn Gastroenterology, New York, USA. 2011. "Advanced Endoscopy and Endosonography" ("Advanced Endoscopy and Endosonography")

Articles Published in International Peer-Reviewed Journals (Articles Published in International Peer-Reviewed Journals)

1. Gültekin, F, Erdoğan GH, Özensoy U, Alagozlu H. The effects of angiotensin-converting enzyme inhibitors on the clinical and biochemical parameters in diabetic nephropathy. Ren Fail 1993;15(5):615–622.
2. Alagozlu H, Gültekin F, Candan F. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?. Nutr Metab Cardiovasc Dis 2000;10(4), 204–208.
3. Tellioglu AT, Uras KA, Yılmaz T, Alagozlu H, Tekdemir I, Karabag O. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg 2001; 108(4):959-962.
4. Alagozlu H, Candan F, Gültekin F, Bulut E, Elagöz Ş. Horseshoe kidney and nephrotic syndrome due to idiopathic membranous nephropathy. Intern Med 2001; 40(12),1259–1260.
5. Candan F, Alagozlu H. Captopril inhibits the pulmonary toxicity of paraquat in Rats. Hum Exp Toxicol 2001;20(12):637–641.
6. Alagozlu H, Bakıcı Z, Gültekin F, Yıldırım B, Sezer H. Anticardiolipin antibody positivity in diabetic patients with and without diabetic foot. J Diabetes Complications. 2002;16(2):172–175.
7. Candan F, Alagozlu H, Poyraz O, Sümer H. Prevalence of hepatitis B and C virus infection in barbers in the Sivas region of Turkey. Occup Med (Lond) 2002;52(1):31–34.
8. Erselcan T, Alagozlu H, Candan F, Turgut F. Usefulness of measuring the gastric emptying time in a case of brittle diabetes. Ann Nucl Med 2004;18(6):533–535.
9. Gültekin F, Alagozlu H, Candan F, Nadir I, Bakici MZ, Sezer H. The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis. ASAIO J 2005;51(2):162–164.
10. Alagozlu H, Cindoruk M, Karakan T, Unal S. Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis. Dig Dis Sci 2006; 51(5):931–933.
11. Alagozlu H, Cindoruk M, Unal S. Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis. Clin Drug Investig 2006;26(5):297–302.
12. Alagozlu H, Cindoruk M, Unal S. Severe INR elevation in a patient with choledocholithiasis receiving cefoperazone. Clin Drug Investig 2006;26(8):481–484.
13. Simsek Z, Alagozlu H, Tuncer C, Dursun A. Lymphocytic Colitis associated with Lansoprazole treatment. Current Therapeutic Research 2007;68(5):360–366.
14. Alagozlu H, Ergun M, Cindoruk M, Unal S, Dumlu S, Poyraz A, Dursun A. The rare presentations of a large polyp and an esophageal carcinoma in heterotropic gastric mucosa: a case series. J Med Case Reports 2007;1:127.
15. Ergun M, Cindoruk M, Alagozlu H, Unal S, Karakan T, Dursun A. Hypertrophic colonic turberculosis mimicking tumourous mass. Colorectal Dis 2008; 10(7):735-736.
16. Alagozlu H, Unal S, Karakan T, Cindoruk M, Ergun M. Small-volume Gallbladders and Decreased Motility in Patients With Achalasia. J Clin Gastroenterol 2008; 42(2):191–193.
17. Erkan G, Alagõzlü H, Memiş L, Tuncer C. Rapidly growing giant solitary cavernous hemangioma in a patient with ulcerative colitis. Turk J Gastroenterol 2008 Dec;19(4):271-5.
18. Karakan T, Cindoruk M, Alagozlu H, Ergun M, Dumlu S, Unal S. EUS versus endoscopic retrograde cholangiography for patients with intermediate probability of bile duct stones: a prospective randomized trial. Gastrointest Endosc 2009;69(2):244-52.
19. Kustimur S, Al FD, Tuncer C, Camurdan AD, Dalgıc B, Alagozlu H, Berk E. Investigation of Some Protozoans with Different Diagnostic Methods in Patients with Gastrointestinal Discomfort. Turkiye Klinikleri J Med Sci 2009; 29(5):1260–1266.
20. Alagozlu H, Simsek Z, Unal S, Cindoruk M, Dumlu S, Dursun A. Is there an association between Helicobacter Pylori in the Inlet Patch and Globus Sensation? World J Gastroenterol 2010; 7: 16 (1):42–7.
21. Yıldırım B, Tuncer C, Kan D, Tunc B, Demirag MD, Ferda Percın E, Haznedaroglu S, Alagozlu H. MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients. Rheumatol Int 2011; 31(7): 859–64.
22. Karadayı K, Turan M, Karadayı Ş, Alagozlu H, Kılıckap S, Buyukcelik A, Sarkıs C, Yucel B, Boztosun A, Cetin M, Yilmaz A, Yanik A, Sen M. Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: Morbidity and Mortality Analysis of Our Patients. Turkiye Klinikleri J Med Sci 2012;32(1):162–70.
23. Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo G, Whitcomb DC, Windsor JA; Pancreatitis Across Nations Clinical Research and Education Alliance (PANCREA). Ann Surg. 2012;256(6):875-80.
24. Abu Hilal M, Abu-Zidan FM, Acosta JM, Ainsworth AP, Aizcorbe Garralda M, Alagozlu H, Al'aref SJ, Albeniz Arbizu E, Alhajeri A, Almeida IC,... Ann Surg. 2012;256(6):875-80.
25. Alagozlu H, Gorgul A, Bilgihan A, Tuncer C, Unal S. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stres in patients with active ulcerative colitis. Clin Res Hepatol Gastroenterol. 2013;37(1):80-5.
26. Yılmaz A, Alagozlu A, Ozdemir O, Arici S. Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients. Hepat Mon. 2014; 14(7):e11283.

Papers Presented and Published in Abstract Books at National Scientific Meetings (Papers Presented and Published in Abstract Books at National Scientific Meetings)

27. Türkay C, Dökmetaş HS, Topcu S, Alagözlü H, Gültekin F, İçağasıoğlu S. Thyroid Functions in Patients with Chronic Renal Failure. XI. National Congress of Renal Diseases, Dialysis and Transplantation, 167, Samsun, 1994.
28. Candan F, Alagözlü H, Topcu S. The effect of Dexfenfluramine on platelet aggregation in Obese Patients. 19. National Congress of Endocrinology-Diabetology and Endocrine Surgery, 08-12, Istanbul, 1996.
29. Akbayır N, Cevit R, Alagözlü H. Combination of Azithromycin and Tetracycline in Ranitidine Bismuth Citrate Based, Short-Term, Triple Therapy in Helicobacter Pylori Eradication. XIV. National Congress of Gastroenterology, 39, Istanbul, 1998.
30. Alagözlü H, Yılmaz K, Aktaş C, Özbay S. Analysis of Our Intoxication Cases. 3. National Congress of Internal Medicine,178-179, Antalya, 2001.
31. Elaldı N, Şencan M, Dökmetaş İ, Bakır M, Alagözlü H, Bilgiç A. Hemophagocytic syndrome: Two case reports. X. Turkish Congress of Clinical Microbiology and Infectious Diseases, 357-358, Adana, 2001.
32. Yılmaz K, Alagözlü H, Kukul G, Özbay S. Etiological distribution of patients admitted with abdominal pain complaint. 18. National Gastroenterology Week, 97, Antalya, 2001.
33. Yılmaz A, Alagözlü H, Kukul FM, Özbay S, Arıkan O, Korkmaz İ. Gastrointestinal system bleedings in the Emergency Department. 19. National Congress of Gastroenterology, 146, Antalya, 2002.
34. Oğuztürk H, Alagözlü H, Elaldı N. Investigation of Cryptosporidium spp in Sivas region. XIII. National Congress of Parasitology, 227, Konya, 2003.
35. Nadir A, Kaptanoğlu M, Şahin E, Durkaya S, Alagözlü H, Toksoy H. Esophageal foreign bodies: Evaluation of 136 cases. II. Turkish Congress of Thoracic Surgery, 19, 2003.
36. Alagözlü H, Yılmaz A, Üskülütaş S. Plasma and intraerythrocytic magnesium levels in patients with hypertensive type 2 diabetes Mellitus. 5. National Congress of Internal Medicine, 165, Antalya, 2003.
37. Yılmaz A, Alagözlü H, Aktaş C, Varol O, Oğuztürk H. Mushroom poisoning cases followed up in the Emergency Department Observation Unit. 5. National Congress of Internal Medicine, 194, Antalya, 2003.
38. Eren HŞ, Yılmaz A, Alagözlü H, Güven M. Serum homocysteine level in hypertensive patients and its relationship with dyslipidemia. 21. National Congress of Nephrology, Hypertension, Dialysis and Transplantation, 48, 2004.
39. Alagözlü H. Gastroenterological Emergencies. 2. Gazi Internal Medicine Days, 90-99, Ankara, 2005.
40. Alagözlü H, Simsek Z, Ünal S, Dursun A, Cindoruk M. Evaluation of our cases with heterotopic gastric mucosa in the esophagus. 2. Congress of Hepatogastroenterology, 39, Antalya, 2005.
41. Alagözlü H. Approach to the Patient with Chronic Diarrhea. 3. Gazi Internal Medicine Days, 76-85, Ankara, 2006.
42. Kuştimur S, Doğruman F, Kaya T, Tuncer C, Duyan A, Dalgıç. B, Alagözlü H, Berk E. Parasitological evaluation of stool samples from patients with chronic gastrointestinal symptoms. XXXII. Turkish Congress of Microbiology, 479, Antalya, 2006.
43. Alagözlü H, Ünal S, Dumlu Ş, Cindoruk M, Şimşek Z, Dursun A. Evaluation of our cases with heterotopic gastric mucosa in the esophagus. 3. Congress of Hepatogastroenterology, 216, Antalya, 2006.
44. Alagözlü H, Ünal S, Karakan T, Cindoruk M, Ergün M. Decreased motility in patients with achalasia. 3. Congress of Hepatogastroenterology, 217, Antalya, 2006.
45. Alagözlü H, Cindoruk M, Dumlu Ş, Ünal S. Diagnostic value of endoultrasonography in balj (bulgy) lesions of the esophagus, stomach and duodenum. 3. Congress of Hepatogastroenterology, 218, Antalya, 2006.
46. Alagözlü H. GMO and GIS (Genetically Modified Organisms and Gastrointestinal System). 4. Gazi Internal Medicine Days, 89-93, Ankara, 2007.
47. Alagözlü H. Esophageal impedance analysis. 4. Congress of Hepatogastroenterology, 146-148, Antalya, 2007.
48. Alagözlü H, Yılmaz A, Gürbüz Ö. Acute pancreatitis due to Hypertriglyceridemia during pregnancy: Case report. 6. Congress of Hepatogastroenterology, 146, Antalya, 2009.
49. Alagözlü H, Timuçin M, Yılmaz A, Özdemir Ö. Investigation of “Multidrug Resistant Gene Mutation” in Hepatitis C patients unresponsive to treatment. 6. Congress of Hepatogastroenterology, 129-130, Antalya, 2009.
50. Yılmaz A, Alagözlü H, Özdemir Ö, Arıcı S. Relationship between CCR5 mutation and liver histopathology in Chronic Hepatitis C patients. 6. Congress of Hepatogastroenterology, 130-131, Antalya, 2009.
51. Alagözlü H, Yılmaz A, Bakıcı MZ, Arıcı S. Relationship between Serum “Vascular Endothelial Growth Factor” level and histological and biochemical markers of the liver in Chronic Hepatitis C Patients. 6. Congress of Hepatogastroenterology, 146-147, Antalya, 2009.
52. Şimşek Z, Ünal S, Doğan İ, Cindoruk M, Alagözlü H. Sacrococcygeal Agenesis: A rare cause of constipation. 6. Congress of Hepatogastroenterology, 171-172, Antalya, 2009.
53. Şimşek Z, Alagözlü H, Börcek P, Ataoğlu Ö, Cindoruk M, Ünal S. Pyogenic granuloma case in cervical esophagus treated endoscopically. 6. Congress of Hepatogastroenterology, 180-181, Antalya, 2009.
54. Alagözlü H. Genetically Modified Organisms and Gastrointestinal System. 7. Congress of Hepatogastroenterology, 77-81, Antalya, 2010.
55. Karadayı K, Turan M, Karadayı Ş, Alagözlü H, Kılıçkap S, Büyükçelik A, Şarkış C, Yücel B, Boztosun A, Çetin M, Yılmaz A, Yanık A, Şen M. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal cancers. 28. UGH, 267, Antalya, 2011.
56. Alagözlü H, Kılıçlı F, Cantimur AT. Liver enzyme elevation due to Hyperthyroidism. 9. National Congress of Hepatogastroenterology,44-45, Cyprus, 2012.
57. Alagözlü H, Çakmak E. Rare cause of Budd-Chiari Syndrome: Alveolar Echinococcosis. 9. National Congress of Hepatogastroenterology,46, Cyprus, 2012.
58. Alagözlü H, Koç İ, Cantimur AT. Importance of stent placement in clot formation within the choledochus due to Thrombocytopenia. 9. National Congress of Hepatogastroenterology,100-101, Cyprus, 2012.
59. Alagözlü H, Çiçekli E, Genç Ö. Effect of special protocol created by adding Synbiotic to classical treatments on Helicobacter Pylori. Probiotic, Prebiotic and Functional Foods Congress, 61, Antalya, 2013.
60. Alagözlü H, Çiçekli E, Genç Ö, Uslu AU. Eradication achieved by adding Synbiotics to treatment in H.Pylori patients resistant to classical treatments. Probiotic, Prebiotic and Functional Foods Congress, 60, Antalya, 2013.
61. Önlü H, Kıran F, Mokrani M, Sakyp Z, Alagözlü H, Osmanağaoğlu Ö. Determination of the viability of Pediococcus Pentosaceus Ozf Strain encapsulated with whey powder under In Vitro Gastrointestinal conditions. Probiotic, Prebiotic and Functional Foods Congress, 16, Antalya, 2013.
62. Alagözlü H, Gültekin G, Çiçekli E. Treatment achieved with the use of Silymarin in a case with alcoholic liver disease. 9. National Congress of Hepatology, 273-274, Istanbul, 2013.
63. Alagözlü H, Çiçekli E, Gültekin G. Adding Synbiotic to treatment and negativization of HDV-RNA in a patient with chronic delta agent Hepatitis B infection. 9. National Congress of Hepatology, 166-167, Istanbul, 2013.
64. Alagözlü H, Keleş Z, Çiçekli E, Kılıçlı MF. Detection of hepatocellular damage in a patient with hyperthyroidism due to Graves' disease. 30. National Gastroenterology Week, 179, Antalya, 2013.
65. Alagözlü H, Keleş Z, Olcaş İK, Çiçekli E. Autoimmune hepatitis-like liver damage triggered by Diclofenac potassium. 30. National Gastroenterology Week, 180, Antalya, 2013.
66. Alagözlü H, Çiçekli E, Kılıçlı MF. A rare cause of Steatohepatitis: Hyperprolactinonemia case.10. National Congress of Hepatogastroenterology, 131, Magosa, TRNC (Turkish Republic of Northern Cyprus), 2013.
67. Çiçekli E, Alagözlü H. Association of Celiac disease in a Takayasu's arteritis patient with elevated liver enzymes. 10. National Congress of Hepatogastroenterology, 132, Magosa, TRNC (Turkish Republic of Northern Cyprus), 2013.